BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28408996)

  • 21. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
    Syed A; Cross RK; Flasar MH
    Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease.
    Myrelid P; Olaison G; Sjödahl R; Nyström PO; Almer S; Andersson P
    Dis Colon Rectum; 2009 Aug; 52(8):1387-94. PubMed ID: 19617749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?
    White EC; Melmed GY; Vasiliauskas E; Dubinsky M; Ippoliti A; McGovern D; Targan S; Fleshner P
    Dis Colon Rectum; 2012 May; 55(5):563-8. PubMed ID: 22513435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Practical Predictive Index for Intra-abdominal Septic Complications After Primary Anastomosis for Crohn's Disease: Change in C-Reactive Protein Level Before Surgery.
    Zuo L; Li Y; Wang H; Zhu W; Zhang W; Gong J; Li N; Li J
    Dis Colon Rectum; 2015 Aug; 58(8):775-81. PubMed ID: 26163957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of adipose tissue for predicting Crohn's disease postoperative endoscopic recurrence and anastomotic ulcer.
    Yang L; Liu G; Zhang Y; Yao B; Wu Q; Peng L; Wang X; Yuan L
    Int J Colorectal Dis; 2023 Jun; 38(1):170. PubMed ID: 37328584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies.
    Huang W; Tang Y; Nong L; Sun Y
    J Crohns Colitis; 2015 Mar; 9(3):293-301. PubMed ID: 25572276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres.
    de Buck van Overstraeten A; Eshuis EJ; Vermeire S; Van Assche G; Ferrante M; D'Haens GR; Ponsioen CY; Belmans A; Buskens CJ; Wolthuis AM; Bemelman WA; D'Hoore A
    Br J Surg; 2017 Nov; 104(12):1713-1722. PubMed ID: 28745410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of preoperative steroid or immunosuppressant use on short-term outcomes following colectomy in Crohn's disease patients.
    Valizadeh N; Murray AC; Suradkar K; Al-Mazrou A; Kiran RP
    Tech Coloproctol; 2017 Mar; 21(3):217-223. PubMed ID: 28205051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Preoperative Nutritional Status on the Incidence Rate of Surgical Complications in Patients With Inflammatory Bowel Disease With Vs Without Preoperative Biologic Therapy: A Case-Control Study.
    Yamamoto T; Shimoyama T; Umegae S; Kotze PG
    Clin Transl Gastroenterol; 2019 Jun; 10(6):e00050. PubMed ID: 31136361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does a histologically inflamed resection margin increase postoperative complications in patients with Crohn's disease?
    Aaltonen G; Ristimäki A; Keränen I; Carpelan-Holmström M; Lepistö A
    Scand J Gastroenterol; 2018 Mar; 53(3):279-283. PubMed ID: 29431516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Split stoma in resectional surgery of high-risk patients with ileocolonic Crohn's disease.
    Myrelid P; Söderholm JD; Olaison G; Sjödahl R; Andersson P
    Colorectal Dis; 2012 Feb; 14(2):188-93. PubMed ID: 21689286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressed Patients with Crohn's Disease Are at Increased Risk of Postoperative Complications: Results from the ACS-NSQIP Database.
    Abou Khalil M; Abou-Khalil J; Motter J; Vasilevsky CA; Morin N; Ghitulescu G; Boutros M
    J Gastrointest Surg; 2019 Jun; 23(6):1188-1197. PubMed ID: 30887300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeat intestinal resections increase the risk of recurrence of Crohn's disease.
    Riss S; Schuster I; Papay P; Mittlböck M; Stift A
    Dis Colon Rectum; 2013 Jul; 56(7):881-7. PubMed ID: 23739195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage surgery after failure of endoscopic balloon dilatation versus surgery first for ileocolonic anastomotic stricture due to recurrent Crohn's disease.
    Li Y; Stocchi L; Shen B; Liu X; Remzi FH
    Br J Surg; 2015 Oct; 102(11):1418-25; discussion 1425. PubMed ID: 26313750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A laparoscopic approach reduces short-term complications and length of stay following ileocolic resection in Crohn's disease: an analysis of outcomes from the NSQIP database.
    Lee Y; Fleming FJ; Deeb AP; Gunzler D; Messing S; Monson JR
    Colorectal Dis; 2012 May; 14(5):572-7. PubMed ID: 21831174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative Morbidity After Iterative Ileocolonic Resection for Crohn's Disease: Should we be Worried? A Prospective Multicentric Cohort Study of the GETAID Chirurgie.
    Abdalla S; Brouquet A; Maggiori L; Zerbib P; Denost Q; Germain A; Cotte E; Beyer-Berjot L; Munoz-Bongrand N; Desfourneaux V; Rahili A; Duffas JP; Pautrat K; Denet C; Bridoux V; Meurette G; Faucheron JL; Loriau J; Guillon F; Vicaut E; Benoist S; Panis Y; Lefevre JH;
    J Crohns Colitis; 2019 Dec; 13(12):1510-1517. PubMed ID: 31051502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn's disease: analysis from the PRACTICROHN study.
    Gutiérrez A; Rivero M; Martín-Arranz MD; García Sánchez V; Castro M; Barrio J; de Francisco R; Barreiro-de Acosta M; Juliá B; Cea-Calvo L; Romero C; Borruel Sainz N; Domènech E
    Gastroenterol Rep (Oxf); 2019 Jun; 7(3):168-175. PubMed ID: 31217980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic Dilatation of Crohn's Anastomotic Strictures is Effective in the Long Term, and Escalation of Medical Therapy Improves Outcomes in the Biologic Era.
    Ding NS; Yip WM; Choi CH; Saunders B; Thomas-Gibson S; Arebi N; Humphries A; Hart A
    J Crohns Colitis; 2016 Oct; 10(10):1172-8. PubMed ID: 26971054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients.
    Appau KA; Fazio VW; Shen B; Church JM; Lashner B; Remzi F; Brzezinski A; Strong SA; Hammel J; Kiran RP
    J Gastrointest Surg; 2008 Oct; 12(10):1738-44. PubMed ID: 18709420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Preoperative Use of Biologic Agents on Operative Outcomes in Crohn's Disease Patients.
    Kamel AY; Ayoub F; Banerjee D; Chaudhry N; Ader Y; Tan S; Zimmermann EM; Glover SC; Iqbal A
    Am Surg; 2018 Sep; 84(9):1526-1530. PubMed ID: 30268188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.